Rigged
Check My Profile Posts
- Joined
- Sep 2, 2023
- Posts
- 3,066
- Reputation
- 2,722
- Tazemetostat - 800mg oral 2x a day
- AI - aromasin or something
- Finasteride - 1 mg daily
- Aspirin - 81mg daily
- Nac - 600mg daily
- Coq10 - 100mg daily
- 5-azac - 100mg/m2 subq/iv daily 7 days for 28 day cycle 4 cycles
- B12 - 1000mcg IM 1x a week
- Folic acid - 1mg daily
- G-CSF - 5 mcg/kg daily
- Allopurinol - 100mg daily
- Omeprazole - 20mg daily
- Normal saline - whenever needed
- Regular CBC
- Liver and kidney function tests
- Hormone panels
- Bone density scans every 6 months
So to start EZH2 is a histone methyltransferase component of PRC2 that shows epigenetic control by trimethylating H3K27me3 which causes transcriptional repression of key osteogenic genes like RUNX2. Supressing EZH2 with small molecule inhibitors like Tazemetostat would lower H3K27me3 marks causing a derepression of osteogenic pathways. This would reactivate silenced osteoprogenitor genes in craniofacial mesenchyme boosting controlled/localized osteoblast differentiation and from that craniofacial bone
Next is 5-Azacytidine, it works as a DNA methyltransferase inhibitor including into DNA and inhibiting the methylation of cytosine residues so by preventing hypermethylation it reactivates growth related genes that have become epigenetically silenced, reexpression of chondrocyte related genes in cranial cartilage is possible, influencing cranial suture activity and boosting selective bone expansion, the accurate temporal and spatial use of these epigenetic modulators would be important to prevent offtarget effects and any unwanted systemic exposure
Shout out to @Master for making this possible he does so much for us by keeping this forum opened
Shout out to @MA_ascender @4lt.Real and @oppastoppathe2nd
They have confirmed and stated they will be testing these out for us so lets give them a kiss on the tip to motivate them
Last edited: